Literature DB >> 9767447

Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YT.

F J Kos1, H D Bear.   

Abstract

Ligation of CD28 molecules expressed on the surface of human leukaemic natural killer-like YT cells triggers intracellular signals leading to cytolysis of target cells expressing CD80 or CD86 molecules. Known intracellular events include tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C (PKC). In this study, we report that PKC-delta isoenzyme activity is required for CD28-triggered cytotoxicity mediated by YT cells and we also demonstrate that one of the primary targets of bryostatin 1, a modulator of PKC activity, is PKC-delta. Treatment of YT cells with bryostatin 1 caused degradation of PKC-delta, but not other PKC isoenzymes, and completely blocked the cytolytic activity of YT cells. In addition, PKC-delta-specific antibody introduced into YT cells by electroporation inhibited partially the YT cell-mediated cytotoxicity of B-lymphoblastoid cell line JY. This effect was specific, since addition of anti-PKC-delta antibody-blocking peptide in combination with anti-PKC-delta antibody to YT cells for electroporation, neutralized the effect of this antibody. These results demonstrate that YT cell cytolytic activity is dependent on PKC-delta, which is selectively down-regulated by bryostatin 1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767447      PMCID: PMC1364237          DOI: 10.1046/j.1365-2567.1998.00558.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

Review 2.  Protein kinase C--a question of specificity.

Authors:  L V Dekker; P J Parker
Journal:  Trends Biochem Sci       Date:  1994-02       Impact factor: 13.807

3.  Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR.

Authors:  M Szamel; A Appel; R Schwinzer; K Resch
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

Review 4.  Protein kinase C: is its pivotal role in cellular activation over-stated?

Authors:  S E Wilkinson; T J Hallam
Journal:  Trends Pharmacol Sci       Date:  1994-02       Impact factor: 14.819

5.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

6.  Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.

Authors:  M Szamel; F Bartels; K Resch
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

7.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  H Nakanishi; K A Brewer; J H Exton
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

8.  IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro.

Authors:  F J Kos; A Müllbacher
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells.

Authors:  K Ozawa; Z Szallasi; M G Kazanietz; P M Blumberg; H Mischak; J F Mushinski; M A Beaven
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Bryostatin 1 activates T cells that have antitumor activity.

Authors:  T M Tuttle; T H Inge; C P Wirt; J L Frank; C M McCrady; H D Bear
Journal:  J Immunother (1991)       Date:  1992-08
View more
  1 in total

1.  Nature's bounty - drug discovery from the sea.

Authors:  John J Bowling; Anna J Kochanowska; Noer Kasanah; Mark T Hamann
Journal:  Expert Opin Drug Discov       Date:  2007-11       Impact factor: 6.098

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.